OpenVSafe by OpenVAERS
Search V-safe

EGT-30190-15774

5 vaccinations 5 coded responses 64 check-ins 5 free-text entries 3 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
088 / NJ
Registered
2020-12-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2263422 (opens in a new window) medium 10 / 11 9 1 of 3 VAERS symptoms same dose (4) NJ matches 2022-03-29 / 2022-04-30 / 2022-05-04
received the same day as the last call
case 633830

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2020-12-18
    Registered in v-safe
  2. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-18
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-02
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-01-09
    Dose 2 — Pfizer-BioNTech
  11. 2021-01-09
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  12. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-16
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-01-23
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-01-30
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-06
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-13
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-20
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-10
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-07-10
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-09-03
    Dose 3 — Pfizer-BioNTech
  27. 2021-09-03
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  28. 2021-09-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  29. 2021-09-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2021-09-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  31. 2021-09-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  32. 2021-09-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-09-10
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-09-17
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-09-24
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-10-01
    Survey response — day 28, dose 3
    MedDRA: Exposure to communicable disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: Exposed to rhinovirus from symptomatic nurse coworker with whom I spent last Friday doing endoscopy all day despite her and I both wearing masks, told me around midday she& source case grand daugh tested Covid19 neg consistently & rhinovirus positive
    MedDRA releases: 2024-11 · check-in free text available
  37. 2021-10-08
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-10-15
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-12-04
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-03-04
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-03-29
    Dose 4 — Pfizer-BioNTech
  42. 2022-03-30
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  43. 2022-03-31
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  44. 2022-04-01
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  45. 2022-04-02
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  46. 2022-04-03
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  47. 2022-04-04
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  48. 2022-04-05
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  49. 2022-04-12
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  50. 2022-04-19
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  51. 2022-04-26
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  52. 2022-05-03
    Survey response — day 35, dose 4
    MedDRA: Chills, Cough, Hyperhidrosis, Myalgia, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive, Self-medication, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Sneezing, rhinorrhea, slight cough, feverish, sweating, chills, muscle aches and pains starting Saturday, April 30, tested positive Sunday, May 1, on home rapid antigen nucleocapsid Coronavirus test, started Paxlovid that evening, now resolved and g. · Healthcare visit (other): CVS Pharmacy - I prescribed for myself as I am a doctor.
    MedDRA releases: 2024-11 · check-in free text available
  53. 2022-05-03
    Report sent to call center — day 35, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  54. 2022-05-04
  55. 2022-05-04
    Call successful
    Completed over the phone
  56. 2022-05-10
    Survey response — day 42, dose 4
    MedDRA: COVID-19, Office visit, Pre-existing disease, SARS-CoV-2 test negative, SARS-CoV-2 test positive, Therapeutic response unexpected — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Covid19 home rapid antigen test positive May 1, Covid19 symptoms resolved May 2, PCR positive May 4, rapid antigen negative May 6. Paxlovid 300 mg bid evening May 1-6 morning; side effects dysgeusia, diarrhea, rectal pain resolved. Arthritis cured! · Healthcare visit (other): Employee Health Service
    MedDRA releases: 2024-11 · check-in free text available
  57. 2022-05-10
    Report sent to call center — day 42, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  58. 2022-05-11
    Call successful
    Does not wish to fill out VAERS report
  59. 2022-06-30
    Survey response — 3 months, dose 4
    MedDRA: COVID-19, Medical counselling — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Rebound COVID19 after Paxlovid treated by repeated course of Paxlovid successfully. · Healthcare visit (other): Self treatment with colleague physician advice after literature search and consultation
    MedDRA releases: 2024-11 · check-in free text available
  60. 2022-06-30
    Report sent to call center — 3 months, dose 4
    Get care from a doctor or other healthcare professional
    1 call case(s)
  61. 2022-07-01
  62. 2022-07-01
  63. 2022-07-01
  64. 2022-07-02
    Call successful
    Does not wish to fill out VAERS report
  65. 2022-09-28
    Dose 5 — Pfizer-BioNTech
  66. 2022-09-28
    Health check-in — day 0, dose 5
    Feeling: Good · None
    Adult check-in
  67. 2022-09-29
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness
    Adult check-in
  68. 2022-09-30
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  69. 2022-10-01
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Swelling · None
    Adult check-in
  70. 2022-10-02
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  71. 2022-10-03
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  72. 2022-10-04
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  73. 2022-10-05
    Health check-in — day 7, dose 5
    Feeling: Good · None
    Adult check-in
  74. 2022-10-12
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  75. 2022-10-19
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  76. 2022-10-26
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  77. 2022-11-02
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  78. 2022-11-09
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  79. 2022-12-28
    Survey response — 3 months, dose 5
    MedDRA: Large intestine polyp — Feeling: Good
    Free text: Colon polyp
    MedDRA releases: 2024-11 · check-in free text available
  80. 2023-03-29
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-09Pfizer-BioNTech
32021-09-03Pfizer-BioNTech No
42022-03-29Pfizer-BioNTech No
52022-09-28Pfizer-BioNTech No

Call center

3 call center cases

3 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 9 — day 28, dose 3

2021-10-01

Symptoms: Exposed to rhinovirus from symptomatic nurse coworker with whom I spent last Friday doing endoscopy all day despite her and I both wearing masks, told me around midday she& source case grand daugh tested Covid19 neg consistently & rhinovirus positive cut off by CDC

Release 11 — day 35, dose 4

2022-05-03

Symptoms: Sneezing, rhinorrhea, slight cough, feverish, sweating, chills, muscle aches and pains starting Saturday, April 30, tested positive Sunday, May 1, on home rapid antigen nucleocapsid Coronavirus test, started Paxlovid that evening, now resolved and g. cut off by CDC
Healthcare visit (other): CVS Pharmacy - I prescribed for myself as I am a doctor.

Release 11 — day 42, dose 4

2022-05-10

Symptoms: Covid19 home rapid antigen test positive May 1, Covid19 symptoms resolved May 2, PCR positive May 4, rapid antigen negative May 6. Paxlovid 300 mg bid evening May 1-6 morning; side effects dysgeusia, diarrhea, rectal pain resolved. Arthritis cured! cut off by CDC
Healthcare visit (other): Employee Health Service

Release 12 — 3 months, dose 4

2022-06-30

Symptoms: Rebound COVID19 after Paxlovid treated by repeated course of Paxlovid successfully.
Healthcare visit (other): Self treatment with colleague physician advice after literature search and consultation

Release 12 — 3 months, dose 5

2022-12-28

Symptoms: Colon polyp

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling · · ✓
HCVOOffice visit · · ✓
HCVOSelf-medication · · ✓
SDChills · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDExposure to communicable disease · · ✓
SDHyperhidrosis · · ✓
SDLarge intestine polyp · · ✓
SDMyalgia · · ✓
SDPre-existing disease · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSARS-CoV-2 test positive · · ✓
SDSneezing · · ✓
SDTherapeutic response unexpected · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release